Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000691280 | SCV000819032 | likely benign | Joubert syndrome 20; Meckel syndrome, type 11 | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000691280 | SCV000895032 | uncertain significance | Joubert syndrome 20; Meckel syndrome, type 11 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001724141 | SCV002545813 | likely benign | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | TMEM231: BP4 |
Gene |
RCV001724141 | SCV002571191 | uncertain significance | not provided | 2023-09-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003928169 | SCV004739619 | likely benign | TMEM231-related condition | 2022-08-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724141 | SCV001954323 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001724141 | SCV001964911 | uncertain significance | not provided | no assertion criteria provided | clinical testing |